Both in Pharmaceuticals
Rocket Pharmaceuticals vs Fulcrum Therapeutics
Over the past year RCKT returned −35.0% and FULC returned −62.5%; their daily moves had a correlation of 0.21.
RCKT −35.0% FULC −62.5%Growth of $1, one year, split-adjusted
| Metric | RCKT | FULC |
|---|---|---|
| Price | $2.55 | $3.73 |
| Market cap | $279.4M | $284.9M |
| Today | +3.88% | +0.81% |
| 1 month | −1.7% | +0.8% |
| 6 months | −26.9% | −47.8% |
| Year to date | −27.5% | −67.0% |
| 1 year | −35.4% | −61.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $262.5M | $318.8M |
| Dividend yield | — | — |
| Volatility (60d) | 65.8% | 16.7% |
| Short % of float | 19.2% | 10.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).